TSHA
Taysha Gene Therapies Inc

2,045
Mkt Cap
$1.41B
Volume
559,286.00
52W High
$6.02
52W Low
$1.05
PE Ratio
-14.05
TSHA Fundamentals
Price
$4.59
Prev Close
$4.98
Open
$4.92
50D MA
$4.90
Beta
1.62
Avg. Volume
3.47M
EPS (Annual)
-$0.357
P/B
6.23
Rev/Employee
$114,150.68
Loading...
Loading...
News
all
press releases
Taysha Gene Therapies (NASDAQ:TSHA) Earns Buy Rating from Chardan Capital
Chardan Capital reissued a "buy" rating and issued a $12.00 target price on shares of Taysha Gene Therapies in a research report on Tuesday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of "Moderate Buy" from Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the company, MarketBeat.com reports. One...
MarketBeat·7d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Cut to "Sell" at Wall Street Zen
Wall Street Zen lowered shares of Taysha Gene Therapies from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·9d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Down 4.8% - What's Next?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.8% - Should You Sell...
MarketBeat·10d ago
News Placeholder
Rice Hall James & Associates LLC Buys New Holdings in Taysha Gene Therapies, Inc. $TSHA
Rice Hall James & Associates LLC purchased a new position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) in the third quarter, according to the company in its most recent filing with the...
MarketBeat·15d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - Here's Why
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - What's Next...
MarketBeat·19d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 52-Week High - Here's Why...
MarketBeat·21d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Taysha Gene Therapies from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
1,203,941 Shares in Taysha Gene Therapies, Inc. $TSHA Purchased by Stempoint Capital LP
Stempoint Capital LP purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·1mo ago
News Placeholder
B Group Inc. Buys 545,000 Shares of Taysha Gene Therapies, Inc. $TSHA
B Group Inc. lifted its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 43.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·1mo ago
<
1
2
...
>

Latest TSHA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.